BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21632816)

  • 1. Effect of intensive insulin therapy on the somatotropic axis of critically ill children.
    Gielen M; Mesotten D; Brugts M; Coopmans W; Van Herck E; Vanhorebeek I; Baxter R; Lamberts S; Janssen JA; Van den Berghe G
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2558-66. PubMed ID: 21632816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness.
    Mesotten D; Wouters PJ; Peeters RP; Hardman KV; Holly JM; Baxter RC; Van den Berghe G
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3105-13. PubMed ID: 15240578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intensive insulin therapy on insulin sensitivity in the critically ill.
    Langouche L; Vander Perre S; Wouters PJ; D'Hoore A; Hansen TK; Van den Berghe G
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3890-7. PubMed ID: 17666481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose dysregulation and neurological injury biomarkers in critically ill children.
    Vanhorebeek I; Gielen M; Boussemaere M; Wouters PJ; Grandas FG; Mesotten D; Van den Berghe G
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4669-79. PubMed ID: 20668035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors.
    de Groof F; Joosten KF; Janssen JA; de Kleijn ED; Hazelzet JA; Hop WC; Uitterlinden P; van Doorn J; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3118-24. PubMed ID: 12107211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone/insulin-like growth factors axis in children undergoing cardiac surgery.
    Balcells J; Moreno A; Audí L; Roqueta J; Iglesias J; Carrascosa A
    Crit Care Med; 2001 Jun; 29(6):1234-8. PubMed ID: 11395611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derangements of the somatotropic hormone axis in chronic renal failure.
    Tönshoff B; Blum WF; Mehls O
    Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like Growth Factor I and its binding protein 3 in sepsis.
    Papastathi C; Mavrommatis A; Mentzelopoulos S; Konstandelou E; Alevizaki M; Zakynthinos S
    Growth Horm IGF Res; 2013 Aug; 23(4):98-104. PubMed ID: 23611528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Effects of Intraperitoneal and Subcutaneous Insulin Administration on the GH-IGF-1 Axis in Type 1 Diabetes.
    van Dijk PR; Logtenberg SJ; Chisalita SI; Hedman CA; Groenier KH; Gans RO; Kleefstra N; Arnqvist HJ; Bilo HJ
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2493-501. PubMed ID: 27115061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of intensive insulin therapy on the mortality of critically ill patients in intensive care unit: a meta-analysis].
    Li J; Li L; Ma B; Yang KH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jun; 21(6):349-52. PubMed ID: 19570341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
    Laughlin GA; Dominguez CE; Yen SS
    J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of growth velocity and the insulin-like growth factor system in children with acute lymphoblastic leukemia: a longitudinal study.
    Argüelles B; Barrios V; Pozo J; Muñoz MT; Argente J
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4087-92. PubMed ID: 11095437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
    Clemmons DR; Sleevi M; Allan G; Sommer A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2652-8. PubMed ID: 17426090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbed anabolic hormonal patterns in burned patients: the relation to glucagon.
    Nygren J; Sammann M; Malm M; Efendic S; Hall K; Brismar K; Ljungqvist O
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):491-500. PubMed ID: 7586625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
    Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus.
    Bereket A; Lang CH; Blethen SL; Gelato MC; Fan J; Frost RA; Wilson TA
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1312-7. PubMed ID: 7536205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
    Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.